TAZ Antikörper (N-Term, pSer89)
Kurzübersicht für TAZ Antikörper (N-Term, pSer89) (ABIN4889551)
Target
Alle TAZ Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term, pSer89
-
Spezifität
- Reacts with human TAZ pS89 protein
-
Kreuzreaktivität
- Maus, Ratte (Rattus)
-
Kreuzreaktivität (Details)
- Cross reacts with protein from mouse, rat and other specied due to sequence homologie.
-
Aufreinigung
- Purified (protein A)
-
Immunogen
- Synthetic peptide derived from N-term part of the human TAZ protein containing a phosphoserine at position 89
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
WB1:500 - 1:5 000 IF1:200 - 1:1000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Must be reconstituted in distilled water.
-
Konzentration
- 1 mg/mL
-
Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Haltbarkeit
- 24 months
-
-
- TAZ (Tafazzin (TAZ))
-
Andere Bezeichnung
- TAZ
-
Hintergrund
- Transcriptional coactivator which acts as a downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis.
-
UniProt
- Q9GZV5
Target
-